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Abstract
Background:  Many cloned animals have been created by transfer of differentiated cells at G0/G1
or M phase of the cell cycle into enucleated M II oocytes having high maturation/meiosis/mitosis-
promoting factor activity. Because maturation/meiosis/mitosis-promoting factor activity during
oocyte maturation is maximal at both M I and M II, M I oocytes may reprogram differentiated cell
nuclei as well. The present study was conducted to examine the developmental ability in vitro of
porcine embryos reconstructed by transferring somatic cells (ear fibroblasts) into enucleated M I
or M II oocytes.
Results:  Analysis of the cell cycle stages revealed that 91.2 ± 0.2% of confluent cells were at the
G0/G1 phase and 54.1 ± 4.4% of nocodazole-treated cells were at the G2/M phase, respectively.
At 6 h after activation, nuclear swelling was observed in 50.0-88.9% and 34.4-39.5% of embryos
reconstituted with confluent cells and nocodazole-treated cells regardless of the recipient oocytes,
respectively. The incidence of both a swollen nucleus and polar body was low (6.3-10.5%) for all
nocodazole-treated donor cell regardless of the recipient oocyte. When embryos reconstituted
with confluent cells and M I oocytes were cultured, 2 (1.5%) blastocysts were obtained and this was
significantly (P < 0.05) lower than that (7.6%) of embryos produced by transferring confluent cells
into M II oocytes. No reconstructed embryos developed to the blastocyst stage when nocodazole-
treated cells were used as donors.
Conclusions:  Porcine M I oocytes have a potential to develop into blastocysts after nuclear
transfer of somatic cells.
Background
Many cloned animals have been created using M II
oocytes as the recipient cytoplasm (sheep [1,2], cattle
[3,4,5], mouse [6,7], goat [8] and pig [9,10,11]). Matura-
tion/meiosis/mitosis-promoting factor (MPF) activity of
recipient M II oocytes appears to be important for the re-
programming of nuclei of reconstructed embryos. Two
distinct and different protocols emerge for embryo re-
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construction by nuclear transfer when using M II oocytes
as recipients. The first is the transfer of nuclei in G1, S or
G2 phase into the preactivated recipients after reducing
MPF activity and the second is the transfer of nuclei in
GO or G1 phase directly into M II oocytes having high
MPF activity [12]. Recently, it has been shown that when
mouse embryonic stem cells [13] and bovine somatic
cells [14] in the M phase were transferred into non-treat-
ed recipients, the chromosome constitution of recon-
structed embryos was normal in that the second polar
body was excluded after parthenogenetic activation and
the embryos developed to offspring. The first protocol is
effective for production of blastomeres derived cloned
embryos because cell cycle synchronization of embryonic
nuclei is difficult and the majority of blastomeres are in
the S phase at any given time [15,16,17]. In the preacti-
vated oocyte, the nuclear membrane of the donor cells
remains intact due to the low activity of MPF and DNA
synthesis occurs according to the original cell cycle stage
at the time of nuclear transfer [12] and nuclear repro-
gramming occurs during the expansion of the donor nu-
cleus [18,19]. Additionally, nuclei of cells of established
embryonic cell lines are reprogrammed in preactivated
recipient oocytes, porcine embryos reconstituted with
blastocyst-derived cells and preactivated recipients have
the ability to develop to blastocysts [20]. However, there
is only one report in which cloned animals have been
produced from embryos reconstructed by transferring
differentiated cells into preactivated recipient oocytes
[8] and the ability of preactivated recipient oocytes to re-
program differentiated cells is now in debate. When bo-
vine somatic cells were transferred into preactivated
recipient oocytes, the resulting reconstructed embryo
development was limited, since all embryos arrested at
the 8-cell stage regardless of the cell cycle of the donor
cells [14]. Because embryonic genome activation of bo-
vine embryos occurs between the 8- to 16-cell stages [21],
preactivated recipients may not reprogram somatic nu-
clei. In contrast, when nuclei in G0 or G1 phase are trans-
ferred into non-treated recipients, reconstructed
embryos can develop to offspring in many species
[1,2,3,4,5,6,8,9,10,11]. In the M II oocyte, the membrane
of the donor nucleus is broken down and the chromo-
somes are prematurely condensed due to the high activ-
ity of MPF. After parthenogenetic activation, the
membrane reforms and DNA synthesis begins [22]. MPF
activity during oocyte maturation is maximal at both M I
and M II [12]. Because many studies suggest that expo-
sure to high activity of MPF is effective for reprogram-
ming a donor nucleus from a differentiated cell
[1,2,3,4,5,6,7,8,9,10,11,14], M I oocytes may reprogram
somatic cell nuclei as well. In the amphibian, the greatest
yield and most advanced tadpoles came from differenti-
ated somatic cell nuclei injected into M I oocytes [23,24]
compared to M II oocytes [23,25,26], although adults
could not be generated from these reconstructed embry-
os. However, there are no reports that experimentally
tested this hypothesis in mammals. In the present study,
we examined the ability of porcine M I oocytes to repro-
gram somatic cell nuclei.
Results
Cell Cycle Analysis of Donor Cells
The cell cycle stages of ear fibroblasts after reaching con-
fluence or treatment with nocodazole were analyzed us-
ing flow cytometry. Analysis of the cell cycle stages in
confluent cells revealed that 91.2 ± 0.2% of the cells were
at the G0/G1 phase, 2.5 ± 0.1% were at the S phase and
6.4 ± 0.1% were at the G2/M phase. In the population of
cells collected after nocodazole treatment, 31.0 ± 3.6%
were at the G0/G1 phase, 14.8 ± 3.1% were at the S phase
and 54.1 ± 4.4% were at the G2/M phase. Experiments
were repeated 3 times and the data are expressed as
mean ± SEM.
Behaviour before Activation of Donor Cell Nuclei
When confluent cells were transferred into M I oocytes,
the fusion rate (60.2%) was significantly (P < 0.05) high-
er than that (25.8%) of embryos reconstituted with noc-
odazole-treated cells and M I oocytes (Table 1). At 15 h
after fusion, spots of condensed chromatin (Figure 1A
and 1B) were observed in the majority (85.0%) of embry-
os reconstructed by transferring confluent cells and this
percentage was significantly (P < 0.05) higher than that
(63.3%) of embryos reconstituted with nocodazole-treat-
ed cells. When nocodazole-treated cells were transferred
into M I oocytes, one spot of condensed chromatin and
one polar body (Figure 1C) was observed in 13.3% of re-
constructed embryos. Regardless of the cell cycle of the
donor cells, the percentage (3.3-5.0%) of embryos with
swollen nuclei (Figure 1D and 1E) was low.
Behaviour after Activation of Donor Cell Nuclei
As shown in Table 2, when confluent cells were used as
donors, the fusion rate (60.2-62.7%) was significantly (P
< 0.05) higher than that (29.0-33.6%) of nocodazole-
treated cells regardless of the maturation stage of the re-
cipient oocytes. At 6 h after activation, swollen nuclei
were observed in 50.0 and 88.9% of embryos produced
by transferring confluent cells into M I or M II oocytes
with no significant differences. Although 34.4-39.5% of
embryos reconstituted with nocodazole-treated cells had
swollen nuclei, the percentage of embryos with both the
swollen nucleus and polar body (Figure 1F) was only 6.3-
10.5%.BMC Developmental Biology (2001) 1:12 http://www.biomedcentral.com/1471-213X/1/12
Development of Reconstructed Embryos
The cleavage rate (38.2%) of embryos reconstituted with
confluent cells and M II oocytes was significantly (P <
0.05) higher than that (5.3-9.7%) of embryos produced
by transferring confluent or nocodazole-treated cells
into M I oocytes (Table 3). However, this percentage
(38.2%) did not significantly differ from that of embryos
reconstituted with nocodazole-treated cells and M II
oocytes (15.4%). When embryos reconstituted with con-
fluent cells and M I oocytes were cultured, 2 (1.5%) blas-
tocysts (Figure 2) were obtained and this percentage was
significantly (P < 0.05) lower than that of embryos pro-
duced by transferring confluent cells into M II oocytes
(7.6%). There were no significant differences in mean
numbers of cells in the blastocysts between different
maturation stages of the recipient oocytes. No embryos
developed to the blastocyst stage when nocodazole-treat-
ed cells were used as donors regardless of the maturation
stage of the recipient oocytes.
Discussion
The results of the present study demonstrated the in vit-
ro developmental ability to blastocysts of porcine embry-
os reconstituted with somatic cells and enucleated M I
oocytes. To our knowledge, this is the first report that de-
scribes blastocyst formation of embryos reconstituted
with M I oocytes in mammals.
When donor nuclei are transferred into non-treated M II
recipient oocytes that have high MPF activity, various
changes referred to as nuclear remodeling occur in the
introduced nuclei. This phenomenon is considered to in-
volve nuclear structural changes, such as nuclear enve-
lope breakdown, premature chromosome condensation
and pronuclear development and swelling [27,28,29].
Nuclear remodeling is thought to be a result of the ex-
change of proteins between the nuclear and cytoplasmic
compartments [30] and is pre-requisite to or is part of
the reprogramming of gene expression [31,32,33].
Therefore, it is generally considered that the phenome-
non of nuclear swelling is one essential component of the
more complex process of genetic reprogramming [34]. In
the present study, when confluent or nocodazole-treated
cells were transferred into enucleated M I oocytes, nucle-
ar swelling was observed in 34.4-50.0% of reconstructed
embryos after activation. This result suggests that por-
cine M I oocytes can initiate reprogramming of both con-
fluent and nocodazole-treated cells. Moreover, some
reconstructed embryos produced by transferring conflu-
ent cells developed to the blastocyst stage. Because acti-
vation of the embryonic genome occurs by the 4-cell
stage in the pig [21], it is evident that donor nuclei were
at least partially reprogrammed in these blastocysts.
Therefore, our results clearly indicate that porcine M I
oocytes like M II oocytes have the ability to reprogram
confluent somatic cell nuclei as determined by nuclear
remodeling and in vitro development.
The blastocyst formation rate of reconstructed embryos
produced by transferring confluent cells into M I oocytes
was significantly lower than that of embryos reconstitut-
ed with confluent cells and M II oocytes although there
were no significant differences in percentages of embry-
os with swollen nuclei between different maturation
stages of recipient oocytes. These results suggest that the
reprogramming of donor nuclei may be started but is not
completed in some embryos reconstituted with M I
oocytes. It has been suggested that nuclear swelling may
not necessarily be a sufficient indicator of developmental
potential in a reconstructed embryo [28]. In addition to
MPF, mitogen-activated protein (MAP) kinase is also
known as an important protein kinase that regulates the
meiotic cell cycle [35]. In mouse oocytes, MAP kinase
plays a more important role in controlling chromatin and
microtubule behavior than MPF [36]. However, MAP ki-
nase and MPF activities do not vary between M I and M
II of porcine oocytes because phosphorylations of MAP
kinase and histone H1 kinase which corresponds to MPF
Table 1: Nuclear swelling and polar body formation at 15 h after fusion in porcine embryos reconstructed by transferring confluent 
(CON) or nocodazole-treated (NOC) cells into enucleated M I oocytes
No. of embryos with
No. of complexes No. of embryos Condensed chromatin Swollen nucleus
Donor
No. of
trials Treated Fused (%)a Examined Surviving
No 
chromatin
/nucleus One Two
One &
polar
body (%)b
Total
(%)b One Two
Total
(%)b
CON 3 128 77 (60.2)c 40 40 4 34 0 0(0) 34 (85.0)c 2 0 2 (5.0)
NOC 4 248 64 (25.8)d 32 30 10 9 6 4(13.3) 19 (63.3)d 0 1 1 (3.3)
aPercentage of complexes treated. bPercentage of embryos surviving. c-dValues with different superscripts are significantly different (P < 0.05).BMC Developmental Biology (2001) 1:12 http://www.biomedcentral.com/1471-213X/1/12
activity reach the peak level at M I and remain high be-
yond M II [37,38]. Potentially, an unknown factor(s) is
required for reprogramming of nuclei, which is present
in M II oocytes but may not be present or active in M I
Figure 1
Nuclear swelling and polar body formation in porcine reconstructed embryos. Embryos containing one (A) or two
(B) spots of condensed chromatin, one spot of condensed chromatin and one polar body (C), one (D) or two (E) swollen
nuclei or one swollen nucleus and one polar body (F). Embryos were reconstructed by transferring confluent (A and D) or
nocodazole-treated (B, C, E and F) cells into enucleated M I oocytes. Bar 100 µm.BMC Developmental Biology (2001) 1:12 http://www.biomedcentral.com/1471-213X/1/12
oocytes. It is known that pronuclear exchange between
zygotes does not prevent development of the recon-
structed embryos [39] but transfer of donor nuclei from
later developmental stages into enucleated zygotes
brings about restricted development [40,41]. One expla-
nation of this phenomenon is that a factor(s) required for
reprogramming of donor nuclei is removed with the pro-
nuclei from recipient zygotes. Similarly, the factor(s)
would be present near the chromosomes at M I and re-
moved with the M I plate during enucleation in many
oocytes. In contrast, the factor(s) is believed to be in cy-
toplasts derived from M II oocytes because embryos re-
constituted with donor nuclei from later developmental
stages and enucleated M II oocytes can develop to adults
[42]. An alternative cause is the effect of cytochalasin B,
a microfilament polymerization inhibitor. In the present
study, reconstructed embryos produced by transferring
confluent cells into M I oocytes were cultured in the mat-
uration medium supplemented with cytochalasin B to
prevent loss of chromosomes by polar body formation.
However, it has been reported recently that morphologi-
cally normal M I spindles are formed but further meiotic
progression does not occur in porcine oocytes matured
in a cytochalasin B-containing medium [38]. Therefore,
it is possible that reprogramming of nuclei transferred
into M I oocytes is inhibited by cytochalasin B. Thirdly,
M I and M II oocytes may differ in cytoplasmic compe-
tence. When porcine M I oocytes are inseminated with
spermatozoa in vitro, the formation rate of male and fe-
male pronuclei is significantly lower than that in M II
oocytes [43]. Finally, optimal conditions for activation
may vary between M I and M II oocytes. To our knowl-
Figure 2
A porcine blastocyst developed from embryos reconstituted with confluent adult somatic cells and enucleated
M I oocytes matured in a protein-free medium. Bar 100 µm.BMC Developmental Biology (2001) 1:12 http://www.biomedcentral.com/1471-213X/1/12
edge, there are no reports that describe activation of MI
oocytes in mammals. Parameters of the activation pulse
used in the present study were also optimized in a pre-
liminary experiment using M II oocytes. It is possible
that optimization of methods for activation improves the
development of embryos reconstituted with M I oocytes.
In contrast, no reconstructed embryos developed to the
blastocyst stage regardless of the maturation stage of the
recipient oocytes when nocodazole-treated cells were
transferred, although nuclear swelling was observed in
34.4-39.5% of the embryos. When cells in M phase are
used as donors, reconstructed embryos with a polar body
are diploid but embryos without a polar body are tetra-
ploid [14]. In the present study, the percentage of embry-
os with both a swollen nucleus and a polar body was low
after transfer of nocodazole-treated cells. In the bovine,
the potential of reconstructed embryos with or without
the polar body to develop to the blastocyst stage is not
different [14]. However, this study suggests that porcine
tetraploid embryos may not develop to blastocysts.
In the present study, there was a significant difference in
fusion rates between the cell cycles of donor cells. The
plasma membrane of nocodazole-treated cells was weak
compared to that of confluent cells and many cells were
broken before and after applying a fusion pulse. Param-
eters of the fusion pulse were optimized in a preliminary
experiment using confluent cells. Therefore, it is expect-
ed that optimal conditions for fusion vary among cell cy-
cles of donor cells in the pig.
In general, in vitro maturation (IVM) media used to pre-
pare recipient oocytes for production of cloned embryos
are usually supplemented with fetal calf serum (FCS)
[3,4,5,14] or porcine follicular fluid (pFF) [11,20,44]. It is
a well known fact that growth factors and hormones, in
addition to many other factors, are abundant in serum
[45,46] and follicular fluid [45,47,48]. Therefore, sup-
plementation of IVM media with FCS or pFF presents
the potential problems in proper quality control and re-
peatability among laboratories or replicates. Recently, a
defined IVM system for porcine oocytes was developed
in order to eliminate such variability [49,50]. In the
present study, 7.6% of reconstructed embryos produced
by transferring confluent adult somatic cells into enucle-
ated M II oocytes matured in the protein-free medium
developed to the blastocyst stage. The blastocyst forma-
tion rate in our study is similar to results from the recent
reports in which porcine adult somatic (cumulus) cells
(5-10%) [29,51] or fetal fibroblasts (1-16%)
[11,29,51,52,53,54,55,56,57] were transferred into enu-
cleated M II oocytes matured in media supplemented
with pFF. In addition, quality of the blastocysts based on
the mean number of cells (45.1 cells) equals if not ex-
ceeds results from previous studies (cumulus cells: 28.9
cells [51]; fetal fibroblasts: 12.5-66.0 cells
[11,51,52,53,54,55,56]). Although this study did not com-
pare defined IVM medium with complex medium the re-
sults indicate that protein-free IVM medium is suitable
for maturing recipient oocytes for the production of
cloned embryos. The defined conditions will allow us to
examine factors affecting nuclear reprogramming of re-
constructed embryos more precisely and better under-
stand the basic molecular mechanisms of the process.
Conclusions
We have shown that porcine M I oocytes have a potential
to develop into blastocysts after nuclear transfer of so-
matic cells. However, the process of nuclear reprogram-
ming may be different between M I and M II oocytes
because developmental abilities of reconstructed embry-
os vary between the maturation stages of recipient
oocytes. Comparison of reprogramming events between
M I and M II oocytes would bring about important infor-
mation to understand the mechanisms of nuclear repro-
gramming in reconstructed embryos. The use of defined
IVM medium will be useful for these studies. Taken to-
gether, the use of a defined medium and optimal repro-
gramming conditions such as the type of donor nuclei
and recipient oocyte will lead to improvements in por-
cine cloning outcomes.
Materials and Methods
Donor Cells
Porcine fibroblasts were harvested from an ear skin bi-
opsy obtained from an adult pig. The tissue was finely
minced and digested in 0.125% (w/v) trypsin/0.02% (w/
v) EDTA solution (Sigma Chemical Co., St. Louis, MO)
containing 1 mg/ml collagenase (Sigma) and 0.3 mg/ml
hyaluronidase (Sigma) for 2 h at 37°C. After digestion,
the mixture was filtered through four layers of sterile
gauze and cells were pelleted by centrifugation. Cells
were cultured in DMEM/F-12 medium (Sigma) supple-
mented with 20% (v/v) FCS (Biowhittaker Inc., Walkers-
ville, MD) under 5% CO2 in air at 37°C. After reaching
confluence, cells were passaged. Passage 2 fibroblasts
were trypsinized, suspended in the culture medium with
10% (v/v) dimethyl sulfoxide (Sigma) and stored as fro-
zen aliquots. Donor cells were used for nuclear transfer
between passages 3 and 9 of culture. For preparation of
donors in G0/G1 phase, the cells were allowed to grow to
confluency by culturing for 6 days and a single cell sus-
pension was prepared by standard trypsinization. The
cells were used for nuclear transfer within 5 days after
reaching confluence. After 2-4 days of subculturing, the
cells (approximately 50% of confluency) were cultured in
the medium supplemented with 0.3 µg/ml nocodazole
(Sigma), a microtubule polymerization inhibitor, for 10 h
to induce G2/M phase arrest. After gentle pipetting, cellsBMC Developmental Biology (2001) 1:12 http://www.biomedcentral.com/1471-213X/1/12
floating in the medium were collected. Both donor cells
were prepared immediately prior to nuclear transfer.
Recipient Oocytes
Ovaries were collected from a local slaughterhouse and
transported in 0.9% saline at approximately 32°C. Folli-
cles greater than 3 mm in diameter were aspirated with
an 18-gauge needle using vacuum suction (100 mmHg;
28 ml/min). Aspirated oocytes that had an evenly granu-
lated cytoplasm and were surrounded by at least two uni-
form layers of compact cumulus cells were selected and
washed three times in Hepes-buffered synthetic oviduc-
tal fluid medium [58]. Oocytes were transferred into
tubes containing Hepes-buffered TCM-199 (Gibco BRL,
Grand Island, NY) supplemented with 0.57 mM cysteine,
10 ng/ml epidermal growth factor (Sigma), 100 IU/ml
penicillin, 100 µg/ml streptomycin, 0.25 ng/ml ampho-
tericin, 0.01 IU/ml porcine FSH (Sioux Biochemicals,
Sioux Center, IA), 0.01 IU/ml porcine LH (Sioux Bio-
chemicals) and 0.1% (w:v) polyvinyl alcohol (maturation
medium) [50], and shipped to the laboratory overnight
(20-24 h) at 38.5°C. Oocytes continued to be cultured in
the tubes under 38.5°C until enucleation.
Nuclear Transfer
Reconstructed embryos were produced using a modifica-
tion of the method described by Miyoshi et al. [44]. Cu-
mulus cells were removed by vortexing with 0.1% (w:v)
hyaluronidase and denuded oocytes were transferred
into 100 µl of Hepes-buffered TCM-199 supplemented
with 7.5 µg/ml cytochalasin B (Sigma) and 10% FCS with
the osmolarity adjusted to 300 mOsm by adding sorbitol
(manipulation medium) at 29 or 42 h after IVM. The M I
plate or the first polar body and M II plate were removed
by aspiration with a 15-µm inner diameter glass pipette.
The oocytes had been previously stained in the manipu-
lation medium supplemented with 5 µg/ml Hoechst
33342 (Sigma) for 20 min and confirmation of successful
enucleation was achieved by visualizing the cytoplast
and removed cytoplasm under ultraviolet light. After
enucleation, a donor cell was inserted into the perivitell-
ine space of each enucleated oocyte using the same glass
pipette. When nocodazole-treated cells were used as do-
nors, large cells (cell diameter was >15 µm) were select-
ed. In our preliminary experiment, such a relatively large
cytoplasmic volume was typical of cells at the G2/M
phase as described by Wakayama et al. [13]. Cell-oocyte
complexes were washed in TCM-199 supplemented with
10% FCS, transferred to the same medium and kept un-
der 5% CO2 in air at 38.5°C until fusion.
Fusion was performed in a 100 mm dish filled with 15 ml
of Zimmermann fusion medium [59]. Two stainless steel
wires (100 µm diameter) attached to micromanipulators
were used as electrodes. The single cell-oocyte complex
was sandwiched between the electrodes and oriented
with the contact surface between the cytoplast and the
donor cell perpendicular to the electrodes. The distance
between the electrodes was about 100 µm. Membrane fu-
sion was induced by applying a single direct current
pulse of 250 V/mm for a duration of 20 µsec with a pre-
pulse of alternating current field of 5 V, 1 MHz for 2 sec
using an LF 101 Fusion Machine (TR Tech Co., Tokyo,
Japan). Following fusion, the complexes were washed in
G 1.2 medium [60] and cultured for a period of 1 h in 100
µl of the same medium. Fusion rate was then determined
by microscopic examination.
Table 2: Nuclear swelling and polar body formation at 6 h after activation in porcine embryos reconstructed by transferring confluent 
(CON) or nocodazole-treated (NOC) cells into enucleated M I or M II oocytesa
No. of embryos with
No. of complexess No. of embryos Condensed chromatin Swollen nucleus
Recipient Donor Treated
Fused 
(%)b Examined Surviving
No
chromatin
/nucleus One Two
One & 
polar 
body
Total 
(%)c One Two
One & 
polar 
body
(%)c
Total
(%)c
M I CON 128 77 (60.2)d 37 36 5 12 1 0 13(36.1) 18 0 0(0) 18 (50.0)de
NOC 200 58 (29.0)e 32 32 11 7 2 1 10(31.3) 9 0 2 (6.3) 11(34.4)d
M II CON 75 47 (62.7)d 47 45 1 4 0 0 4 (8.9) 38 2 0(0) 40 (88.9)e
NOC 122 41 (33.6)e 41 38 9 7 5 2 14 (36.8) 7 4 4(10.5) 15 (39.5)de
aExperiments were repeated 3 times. bPercentage of complexes treated. cPercentage of embryos surviving. d-eValues with different superscripts are 
significantly different (P < 0.05).BMC Developmental Biology (2001) 1:12 http://www.biomedcentral.com/1471-213X/1/12
Activation of Reconstructed Embryos
Fused embryos were washed once in Zimmermann fu-
sion medium and then placed between 2 wire electrodes
(1 mm apart) of the fusion chamber slide with 15 ml of
the fusion medium. Direct current pulses of 75 V/mm
were applied twice to the embryos for a duration of 60
µsec at intervals of 5 sec.
Examination of Reconstructed Embryos
Before and after activation, fused embryos were stained
with 5 µg/ml Hoechst 33342 for 20 min and then exam-
ined for nuclear swelling and polar body formation un-
der ultraviolet light. The nucleus with a diameter that
was at least twice bigger than the original size of donor
cell nuclei was considered to be a swollen nucleus.
Experimental Studies
Cell Cycle Analysis of Donor Cells
In Experiment 1, the cell cycle stages of confluent and
nocodazole-treated donor cells were analyzed using flow
cytometry. Collected cells (approx. 2 ×  106 cells) were
centrifuged and the pellet was re-suspended in 1 ml of
cold PBS. Then, cells were fixed by adding 4 ml of -20°C
absolute ethanol and stored in -20°C. Before analysis,
cells were centrifuged and the pellet was re-suspended in
1 ml of PBS. Then, 100 µl of DNase-free RNase A (200
µg/ml; Sigma) was added and samples were incubated
for 30 min at 37°C. After incubation, 100 µl of propidium
iodide (1 mg/ml; Sigma) was added into each sample and
cells were analyzed using FACStartPLUS analyzer (Bec-
ton Dickinson, San Jose, CA).
Behavior before Activation of Donor Cell Nuclei
In Experiment 2, we examined the behavior before acti-
vation of donor cell nuclei transferred into enucleated M
I oocytes. M I oocytes were enucleated at 29 h after IVM
and confluent or nocodazole-treated cells were trans-
ferred. Fused embryos were cultured in the maturation
medium for 15 h and then examined for nuclear swelling
and polar body formation. When confluent cells were
used as donors, fused embryos were cultured in the me-
dium supplemented with 7.5 µg/ml cytochalasin B to
prevent extrusion of polar bodies.
Behavior after Activation of Donor Cell Nuclei
In Experiment 3, the behavior of nuclei of confluent or
nocodazole-treated cells transferred into enucleated M I
or M II oocytes was examined after activation. Embryos
reconstituted with M I oocytes were cultured in the mat-
uration medium with or without cytochalasin B for 15 h
and then activated. M II oocytes were enucleated at 42 h
after IVM and embryos reconstituted with them were ac-
tivated at 3 h after fusion. Activated embryos were cul-
tured in 100 µl of G 1.2 medium for 6 h and then
examined for nuclear swelling and polar body formation.
When confluent cells were used as donors, embryos were
cultured in G1.2 medium supplemented with 7.5 µg/ml
cytochalasin B for 2 h after activation to prevent extru-
sion of polar bodies [44].
Development of Reconstructed Embryos
Experiment 4 was undertaken to compare in vitro devel-
opmental abilities of reconstructed embryos produced
by transferring confluent or nocodazole-treated cells
into enucleated M I or M II oocytes as described above.
After culture in G1.2 medium for 3 days, the embryos
were transferred into 100 µl of G2.2 medium [60] and
continued to be cultured. The embryos were examined
for cleavage and blastocyst formation at 2 and 7 days af-
ter culture, respectively. At the end of the culture period,
the number of cells in blastocysts was examined. The
blastocysts were placed on slides with a drop of mount-
ing medium consisting of glycerol and PBS (9:1) contain-
ing 0.1 mg/ml Hoechst 33342. A cover slip was placed on
the top of the blastocysts and the edge was sealed with
fingernail polish. The numbers of nuclei were counted
under ultraviolet light.
Table 3: Development of porcine embryos reconstructed by transferring confluent (CON) or nocodazole-treated (NOC) cells into enu-
cleated M I or M II oocytes
No. (%)b of embryos developed to
No. of No. of Mean no. ± SEM
Recipient Donor
No. of
trials
 complexes 
treated
complexes
fused (%)a
≥  2-cell
(2)c
Blastocyst
(7)c
of cells in
blastocysts
M I CON 4 180 132 (73.3)d 7 (5.3)d 2(1.5)d 19.0 ± 5.0
NOC 4 179 72 (40.2)de 7 (9.7)d 0(0)d -
M II CON 3 227 131 (57.7)d 50 (38.2)e 10 (7.6)e 45.1 ± 6.2
NOC 3 136 39 (28.7)e 6 (15.4)de 0(0)d -
aPercentage of complexes treated. bPercentage of embryos cultured. cNumbers in parentheses indicate the time of examination (days after culture). 
d-eValues with different superscripts within each column are significantly different (P < 0.05).BMC Developmental Biology (2001) 1:12 http://www.biomedcentral.com/1471-213X/1/12
Statistical Analysis
All percentage data were subjected to an arcsin square
root transformation in each replicate and the trans-
formed values were analyzed using one-way (Experi-
ment 2) or two-way (Experiments 3 and 4) ANOVA
followed by Student-Newman-Keuls test. The numbers
of cells in blastocysts were analyzed using Student t-test.
A probability of P < 0.05 was considered statistically sig-
nificant.
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